News | August 18, 2014

Guided Therapeutics Granted Additional Key Patent for LuViva Advanced Cervical Scan

Guided Therapeutics Patent LuViva Advnaced Cervical Scan

August 18, 2014 — Guided Therapeutics Inc. announced that U.S. Patent and Trademark Office granted a new patent with 22 claims that support the technology behind the LuViva Advanced Cervical Scan.

Patent number 8,781,560 B2, entitled “Method and Apparatus for Rapid Detection and Diagnosis of Tissue Abnormalities,” covers the use of two types of spectroscopy in conjunction with images of tissue to detect abnormalities in tissue. Most importantly, the inventions described in the patent function as an additional bridge from theoretical models of tissue spectroscopy to a fully functional, commercially viable cancer detection system that can be utilized as a platform for many types of epithelial cancers.

“This is an important patent that extends additional protections to key aspects of the underlying technology that make LuViva such a powerful tool in the early detection of disease that leads to cervical cancer,” said Gene Cartwright, CEO of Guided Therapeutics. “Our intellectual property creates a foundation on which we build shareholder value and we will continue to aggressively develop additional patents in the U.S. and worldwide.”

Guided Therapeutics now holds 21 patents with four additional patents pending for its light-based biophotonic disease detection technology.

For more information: www.guidedinc.com

Related Content

California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init